A prospective multicenter cohort study of Ninjin-yo’eitou for fatigue, malaise, anorexia and anemia during Olaparib treatment in patients with ovarian cancer: the KCOG-G1904 study
This prospective multicenter cohort study demonstrates that concomitant administration of the traditional Japanese herbal medicine Ninjin'yoeito helps maintain quality of life and significantly improves fatigue in patients with ovarian cancer undergoing olaparib treatment.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For women diagnosed with ovarian cancer, the journey often involves a long period of maintenance therapy designed to keep the disease at bay after initial treatment. One of the most effective tools in this fight is a drug called olaparib, which works by stopping cancer cells from repairing their own damaged DNA, effectively causing them to die off. While this medication has significantly improved survival rates, it comes with a heavy price for many patients: a persistent, draining exhaustion that feels different from ordinary tiredness, along with a loss of appetite and a general sense of unwellness. These side effects can be so severe that they force patients to stop taking the life-saving drug, cutting short the very treatment meant to protect them. Doctors have long searched for ways to ease these symptoms without interfering with the cancer treatment, but standard medical options for this specific type of fatigue have been limited.
In a recent study involving forty-five women across eight hospitals in Japan, researchers explored whether a traditional Japanese herbal medicine, known as Ninjin'yoeito, could help. This herbal blend, made from twelve different plant ingredients, has been used for centuries to treat physical weakness and low energy. The study focused on patients who were already taking olaparib and experiencing at least mild versions of fatigue, weakness, or loss of appetite. The goal was not to test a new cancer drug, but to see if adding this ancient remedy to the modern treatment plan could help patients feel better and stay on their medication longer. The researchers tracked the women for six months, carefully recording how their symptoms changed and how their overall quality of life held up.
The results offered a clear and encouraging picture for those struggling with the daily toll of cancer treatment. While the drug olaparib continued to cause expected side effects like low red blood cell counts, the addition of the herbal medicine appeared to make a significant difference in how the patients felt day to day. Specifically, the women who took the herbal remedy reported a noticeable improvement in their fatigue. Their scores on standardized questionnaires about their well-being showed that the exhaustion lessened, and their sense of malaise, or general unease, also improved. Importantly, this relief did not come with new dangers; the study found no increase in serious side effects when the two treatments were used together. The herbal medicine did not, however, fix the drop in blood counts caused by the cancer drug, suggesting that while it helps with how a patient feels, it does not change the biological way the cancer drug affects the bone marrow.
Perhaps the most telling finding was about timing. The researchers observed that patients who started the herbal medicine at the same time they began the cancer drug, or very shortly after, seemed to fare better than those who waited until their symptoms had already become severe. This suggests that using the remedy proactively, as a shield against the onset of exhaustion, might be more effective than trying to treat it after it has already taken hold. The study also highlighted a gap in how doctors and patients experience illness. While the doctors, using standard medical grading scales, saw only mild changes in the patients' conditions, the patients themselves reported feeling much better. This difference underscores that what a patient feels inside is often the most important measure of whether a treatment is working, even if a blood test or a physical exam does not show a dramatic change.
Ultimately, this study suggests that for women facing the long haul of ovarian cancer maintenance, there is a supportive option that can help preserve their quality of life. The herbal medicine did not cure the cancer or stop the blood count from dropping, but it did help manage the crushing fatigue that often forces people to quit their treatment. By keeping patients feeling strong enough to continue their therapy, this approach could indirectly help them stay alive longer. The researchers noted that while the study was small and did not include a group of patients who did not take the herbal remedy, the results are strong enough to warrant further investigation. They propose that in the future, larger and more controlled studies should be done to confirm these findings, but for now, the evidence points to a simple, low-risk addition to the treatment plan that helps patients endure the difficult journey of cancer care.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.